KDM1A and acute myeloid leukemia: LSD1 represses myeloid differentiation programs through its epigenetic eraser activity and interactions with transcriptional repressors; accordingly, LSD1 inhibition has been shown to induce differentiation of AML blasts and ablate their clonogenic potential [29].